FDA Provides Updates on Cyclospora Action Plan Efforts
The U.S. Food and Drug Administration (FDA) has provided updates on the agency’s Cyclospora Prevention, Response, and Research Action Plan to reflect the current status of the agency’s work to prevent and reduce incidences of cyclosporiasis in the U.S.
In 2021, the FDA released its Cyclospora Prevention, Response, and Research Action Plan, which was developed by the agency’s Cyclospora Task Force and details the FDA’s strategy for reducing the public health burden of foodborne cyclosporiasis in the U.S. The plan also defines the Agency’s priorities for Cyclospora food safety research and is aligned with the spirit of the Food Safety Modernization Act (FSMA) and the New Era of Smarter Food Safety work to combat foodborne illness through preventive efforts.